26 results
Thumbnail

D2.65 - Clinical relevance of sensitizations to pneumoallergens detected in southern Spain

Thumbnail

D2.66 - Deciphering The Molecular Profiles Between Asthma and Urticaria Using Transcriptomic Profiling

Thumbnail

D2.67 - Relation betwween IL-6 and asthma in children and adolescent

Thumbnail

D2.69 - Symptom Variability in Hypereosinophilic Syndrome: Observations From a Large Cohort Study

Thumbnail

D2.70 - The Impact of Comorbidity of respiratory and atopic diseases on Mental Health and Wellbeing: a Community Survey in the US and Eastern Europe

Thumbnail

D2.71 - Comprehensive approach to severe bronchial asthma: a case study and the role of biologic therapy

Thumbnail

D2.72 - Analysis of asthma prevalence and risk factors in infantile atopic dermatitis using data from the Korean national health insurance serice

Thumbnail

D2.73 - Activation-induced marker (AIM) assay to study allergic skin reactions: a case study on p-phenylenediamine

Thumbnail

D2.74 - Analytical Verification of House Dust Mite Allergen Assays on the IMMULITE 2000 XPi System*

Thumbnail

D2.75 - Allergy to insects in children

Thumbnail

D2.76 - When Eosinophilia Persists: Unmasking an Unexpected Diagnosis in a Dupilumab Treated Atopic Dermatitis Patient

Thumbnail

D2.77 - A Novel Neural Network for Quantifying Wheal and Erythema in Skin Prick Testing

Thumbnail

D2.78 - Hypersensitivity Reactions to Biologics in Patients with Th1- and Th17-Driven Immune-Mediated Diseases: A Series of Three Cases

Thumbnail

D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023

Thumbnail

D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters

Thumbnail

D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch

Thumbnail

D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

Thumbnail

D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway

Thumbnail

D2.300 - Fixed Drug Eruption related to the use of NSAIDs

Thumbnail

D2.302 - Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test